HeartBeam (BEAT) announced the appointment of Bryan Humbarger as chief commercial officer, effective January 22. In this newly created role, Humbarger will lead commercial strategy and execution across the company’s initiatives. Most recently, he served as chief commercial officer at the venture-backed surgical guidance company Proprio.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BEAT:
- FDA Clearance for HeartBeam (NASDAQ: BEAT) Highlighted in Medical Device Approvals Roundup
- HeartBeam (NASDAQ: BEAT) to Attend JP Morgan 2026 Annual Healthcare Conference
- HeartBeam (NASDAQ: BEAT) Ranks Second Worldwide in 12-Lead ECG Innovation
- 3 Penny Stocks to Watch Now, 12/18/25
- 3 Penny Stocks to Watch Now, 12/16/25